Total Payments
$371,143
2020 Payments
$1,150
Companies
7
Transactions
259
Payment Breakdown by Category
Other$243,730 (65.7%)
Consulting$59,933 (16.1%)
Travel$48,232 (13.0%)
Research$13,808 (3.7%)
Food & Beverage$3,685 (1.0%)
Education$1,755 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $243,730 | 50 | 65.7% |
| Consulting Fee | $59,933 | 9 | 16.1% |
| Travel and Lodging | $48,232 | 129 | 13.0% |
| Unspecified | $13,808 | 20 | 3.7% |
| Food and Beverage | $3,685 | 48 | 1.0% |
| Education | $1,755 | 3 | 0.5% |
Payments by Type
General
$357,335
239 transactions
Research
$13,808
20 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $180,560 | 92 | $0 (2018) |
| SANOFI US SERVICES INC. | $66,067 | 5 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $63,318 | 64 | $0 (2018) |
| Regeneron Pharmaceuticals, Inc. | $23,911 | 35 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $21,757 | 33 | $0 (2020) |
| Amgen Inc. | $13,531 | 29 | $0 (2018) |
| Ironwood Pharmaceuticals, Inc | $2,000 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $1,150 | 2 | AstraZeneca Pharmaceuticals LP ($1,150) |
| 2019 | $27,744 | 34 | AstraZeneca Pharmaceuticals LP ($20,607) |
| 2018 | $171,054 | 91 | SANOFI-AVENTIS U.S. LLC ($83,488) |
| 2017 | $171,196 | 132 | SANOFI-AVENTIS U.S. LLC ($97,072) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/27/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/27/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/28/2019 | Regeneron Pharmaceuticals, Inc. | PRALUENT (Biological) | — | In-kind items and services | $1,327.49 | Research |
| Study: PRALUENT CLINICAL DEVELOPMENT PROGRAM • Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 11/15/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $31.61 | General |
| 11/06/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $455.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $137.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $133.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $129.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $69.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $52.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $52.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $49.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $36.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $35.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $24.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $24.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/06/2019 | AstraZeneca Pharmaceuticals LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| 09/29/2019 | AstraZeneca Pharmaceuticals LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| 09/29/2019 | AstraZeneca Pharmaceuticals LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| 09/26/2019 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $291.16 | General |
| 09/26/2019 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $139.03 | General |
| 09/26/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 09/26/2019 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $15.00 | General |
| 09/26/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.96 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PRALUENT CLINICAL DEVELOPMENT PROGRAM | Regeneron Pharmaceuticals, Inc. | $11,568 | 15 |
| HEALTH ECONOMICS OUTCOME RESEARCH RELATED TO PRALUENT | Regeneron Pharmaceuticals, Inc. | $1,390 | 2 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AN EVERY FOUR WEEKS TREATMENT REGIMEN OF ALIROCUMAB IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA | Regeneron Pharmaceuticals, Inc. | $849.71 | 3 |
About Dr. Eli Roth, MD
Dr. Eli Roth, MD is a Cardiovascular Disease healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750380341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eli Roth, MD has received a total of $371,143 in payments from pharmaceutical and medical device companies, with $1,150 received in 2020. These payments were reported across 259 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($243,730).
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Cincinnati, OH
- Active Since 07/18/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1750380341
Products in Payments
- PRALUENT (Drug) $154,379
- PRALUENT ALIROCUMAB INJECTION (Biological) $84,249
- NO PRODUCT DISCUSSED (Drug) $69,147
- CIALIS (Drug) $23,100
- Repatha (Biological) $13,531
- FARXIGA (Drug) $5,099
- PRALUENT (Biological) $2,980
- ZURAMPIC (Drug) $2,000
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Cincinnati
Timothy Henry, Md, MD
Cardiovascular Disease — Payments: $731,232
Cardiovascular Disease $731,232
Eugene Chung, M.d, M.D
Cardiovascular Disease — Payments: $471,614
Cardiovascular Disease $471,614
Santiago Garcia, Md, MD
Cardiovascular Disease — Payments: $308,252
Cardiovascular Disease $308,252
Dr. Kamal Shemisa, Md, MD
Cardiovascular Disease — Payments: $290,400
Cardiovascular Disease $290,400
Joseph Choo, M.d, M.D
Cardiovascular Disease — Payments: $274,686
Cardiovascular Disease $274,686
John Corl, Md, MD
Cardiovascular Disease — Payments: $268,780
Cardiovascular Disease $268,780